Literature DB >> 8931842

Nondipping of nocturnal blood pressure is related to urinary albumin excretion rate in patients with type 2 diabetes mellitus.

S Equiluz-Bruck1, C Schnack, H P Kopp, G Schernthaner.   

Abstract

Although cardiovascular and cerebrovascular morbidity and mortality in type 2 diabetic patients is closely related to urinary albumin excretion rate (UAER), the causative mechanisms are not yet identified. The aim of our study was to define the circadian variation of blood pressure (BP) in 72 type 2 diabetic patients (mean age 60 years, mean diabetes mellitus duration: 12 years) in comparison with 41 nondiabetic controls with essential hypertension (mean age 58 years) by using ambulatory blood pressure measurement. Thirty diabetic patients had normal UAER (< 30 mg/24 h), 27 had microalbuminuria (30 to 300 mg/24 h), and 15 had persistent proteinuria (> 300 mg/24 h). Systolic blood pressure during both nighttime and daytime was significantly elevated in type 2 diabetic patients with macroalbuminuria compared to controls and patients with normal UAER. During nighttime even type 2 diabetic patients with microalbuminuria had significantly elevated systolic blood pressure compared to controls with essential hypertension. We also observed a correlation of nocturnal blood pressure to UAER (systolic: r = 0.32, P < .007 and diastolic: r = 0.24, P < .04). Nondipping (defined as a reduction of nocturnal BP < 10%) was observed in 80% of the macroalbuminuric, 74% of the microalbuminuric, but only in 43% of the normoalbuminuric type 2 diabetic patients and in 37% of the controls (P < .04). Since a loss of circadian variation of BP is closely related to vascular complications in nondiabetics, our findings may indicate an important relationship between nondipping of BP and the high morbidity and mortality rate in diabetic patients with increased UAER.

Entities:  

Mesh:

Year:  1996        PMID: 8931842     DOI: 10.1016/0895-7061(96)00302-0

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  13 in total

Review 1.  Circadian rhythm of blood pressure in renal disease.

Authors:  M Schömig; V Schwenger; E Ritz
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

Review 2.  Chronotherapy improves blood pressure control and reduces vascular risk in CKD.

Authors:  Ramón C Hermida; Diana E Ayala; Michael H Smolensky; Artemio Mojón; José R Fernández; Juan J Crespo; Ana Moyá; María T Ríos; Francesco Portaluppi
Journal:  Nat Rev Nephrol       Date:  2013-04-23       Impact factor: 28.314

Review 3.  Cardioprotective effects of SGLT2 inhibitors are possibly associated with normalization of the circadian rhythm of blood pressure.

Authors:  Asadur Rahman; Hirofumi Hitomi; Akira Nishiyama
Journal:  Hypertens Res       Date:  2017-01-19       Impact factor: 3.872

4.  Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes.

Authors:  Kazuo Eguchi; Thomas G Pickering; Satoshi Hoshide; Joji Ishikawa; Shizukiyo Ishikawa; Joseph E Schwartz; Kazuyuki Shimada; Kazuomi Kario
Journal:  Am J Hypertens       Date:  2008-02-21       Impact factor: 2.689

5.  Hypertension and disrupted blood pressure circadian rhythm in type 2 diabetic db/db mice.

Authors:  Wen Su; Zhenheng Guo; David C Randall; Lisa Cassis; David R Brown; Ming C Gong
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-15       Impact factor: 4.733

Review 6.  Nocturnal hypertension: will control of nighttime blood pressure prevent progression of diabetic renal disease?

Authors:  K M Moorthi; Donn Hogan; Empar Lurbe; Josep Redon; Daniel Batlle
Journal:  Curr Hypertens Rep       Date:  2004-10       Impact factor: 5.369

Review 7.  Treatment of hypertension in patients with diabetes mellitus : relevance of sympathovagal balance and renal function.

Authors:  Matthias Weck
Journal:  Clin Res Cardiol       Date:  2007-06-27       Impact factor: 5.460

8.  Masked hypertension in diabetes mellitus: a potential risk.

Authors:  Kazuo Eguchi; Joji Ishikawa; Satoshi Hoshide; Thomas G Pickering; Kazuyuki Shimada; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-08       Impact factor: 3.738

Review 9.  The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal system.

Authors:  Guntram Schernthaner; Carl Erik Mogensen; Gerit-Holger Schernthaner
Journal:  Diab Vasc Dis Res       Date:  2014-09       Impact factor: 3.291

Review 10.  Circadian variations of vasoconstriction and blood pressure in physiology and diabetes.

Authors:  Tianfei Hou; Zhenheng Guo; Ming C Gong
Journal:  Curr Opin Pharmacol       Date:  2021-03-12       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.